Formulation Freedom in Clinical Development: Why Fill2Weight Matters
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Dr. Dave Seaward : 29 July 2022
Cell and Gene Blog Series: Part 6 - Future ATMP Manufacturing Paradigms
Blog 6, the penultimate episode in this series, focuses upon how ATMPs are manufactured along with current trends. In this chapter, Dr Dave Seaward also peers into how equipment and consumables supporting this sector might evolve.
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Pouches are widely used in medical device packaging to provide a sterile barrier when the device itself, or its primary container, cannot inherently...
Dose Delivery Uniformity (DDU) is one of the most persistent challenges in dry-powder inhaler development, and few have tackled it more directly...